New Era for Digital ECG: FDA Requires Digital ECG Submission for Tested Drugs

Bibliographic Details
Main Author:	Wojciech Zareba
Format:	Article
Language:	English
Published:	Wiley 2001-01-01
Series:	Annals of Noninvasive Electrocardiology
Online Access:	https://doi.org/10.1111/j.1542-474X.2001.tb00131.x

id	doaj-27e90545e3764a2a870bc110ab63b47e
record_format	Article
spelling	doaj-27e90545e3764a2a870bc110ab63b47e2021-07-01T15:30:27ZengWileyAnnals of Noninvasive Electrocardiology1082-720X1542-474X2001-01-01711310.1111/j.1542-474X.2001.tb00131.xNew Era for Digital ECG: FDA Requires Digital ECG Submission for Tested DrugsWojciech Zareba0Cardiology Unit, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New Yorkhttps://doi.org/10.1111/j.1542-474X.2001.tb00131.x
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Wojciech Zareba
spellingShingle	Wojciech Zareba New Era for Digital ECG: FDA Requires Digital ECG Submission for Tested Drugs Annals of Noninvasive Electrocardiology
author_facet	Wojciech Zareba
author_sort	Wojciech Zareba
title	New Era for Digital ECG: FDA Requires Digital ECG Submission for Tested Drugs
title_short	New Era for Digital ECG: FDA Requires Digital ECG Submission for Tested Drugs
title_full	New Era for Digital ECG: FDA Requires Digital ECG Submission for Tested Drugs
title_fullStr	New Era for Digital ECG: FDA Requires Digital ECG Submission for Tested Drugs
title_full_unstemmed	New Era for Digital ECG: FDA Requires Digital ECG Submission for Tested Drugs
title_sort	new era for digital ecg: fda requires digital ecg submission for tested drugs
publisher	Wiley
series	Annals of Noninvasive Electrocardiology
issn	1082-720X 1542-474X
publishDate	2001-01-01
url	https://doi.org/10.1111/j.1542-474X.2001.tb00131.x
work_keys_str_mv	AT wojciechzareba newerafordigitalecgfdarequiresdigitalecgsubmissionfortesteddrugs
_version_	1721346795155488768

New Era for Digital ECG: FDA Requires Digital ECG Submission for Tested Drugs

Similar Items